Suppr超能文献

人葡萄膜黑色素瘤细胞系的免疫磁珠分离及体外扩增

Immunomagnetic isolation and in vitro expansion of human uveal melanoma cell lines.

作者信息

Cools-Lartigue Jonathan J, McCauley Cristin S, Marshall Jean-Claude A, Di Cesare Sebastian, Gregoire Francois, Antecka Emilia, Logan Patrick, Burnier Miguel N

机构信息

The Henry C. Witelson Ophthalmic Pathology Laboratory and Registry, McGill University Health Center, Montreal, PQ, Canada.

出版信息

Mol Vis. 2008 Jan 10;14:50-5.

Abstract

PURPOSE

Uveal melanoma (UM) is the most common intra-ocular tumor in adults. Despite advances in diagnosis and treatment, the survival rate of UM has not increased in the last several decades. Approximately 50% of patients will die as a consequence of metastatic disease with the majority of metastases localized to the liver. Due to the lack of lymphatics in the eye, hematogenous dissemination is the predominant means by which UM cells escape the primary site. Our laboratory has recently demonstrated the presence of circulating malignant cells (CMCs) in the blood using both animal models and clinical trails involving UM patients. Current data suggests that all UM patients will be positive for CMCs after diagnosis. Furthermore, some of the phenotypic changes that are necessary for metastatic growth may occur while the cells are circulating in the blood. In this study, we evaluated the efficiency of a panel of antibodies to immunomagnetically isolate CMCs for the purpose of in vitro expansion and genetic, immunological, and phenotypic characterization.

METHODS

In this study, five human uveal melanoma cell lines (92.1, MKT-BR, OCM-1, SP6.5, and UW-1) were immunostained with a panel of antibodies against known melanoma cell surface markers. Staining with monoclonal antibodies PAL M2, NKI C3, NKI/Beteb, and 9.2.27 permitted the generation of a cell surface expression profile in these cell lines. The five human UM cell lines and 92.1 transfected with GFP were subsequently spiked into human blood at concentrations ranging from 1x10(6) cells/ml to 10 cells/ml. Cells were immuno-magnetically isolated at concentrations as low as 10 cells/ml.

RESULTS

Immunomagnetic isolation of all five human UM cell lines tested at concentrations down to 10 cells/ml human blood was achieved only when antibodies were used in combination. Individually, the antibodies did not permit isolation of cells at physiologically relevant concentrations.

CONCLUSIONS

The immunomagnetic isolation method presented in this study can be used to isolate CMCs at physiologically relevant concentrations and at sensitivities comparable to those seen in polymerase chain reactions (PCR). In addition, our data suggests that our method is more efficient and reliable for the isolation of CMCs in UM than the methods currently used.

摘要

目的

葡萄膜黑色素瘤(UM)是成人中最常见的眼内肿瘤。尽管在诊断和治疗方面取得了进展,但在过去几十年中UM的生存率并未提高。约50%的患者会因转移性疾病死亡,大多数转移灶位于肝脏。由于眼内缺乏淋巴管,血行播散是UM细胞逃离原发部位的主要途径。我们实验室最近通过动物模型和涉及UM患者的临床试验证明了血液中存在循环恶性细胞(CMC)。目前的数据表明,所有UM患者在诊断后CMC均为阳性。此外,转移生长所需的一些表型变化可能在细胞在血液中循环时发生。在本研究中,我们评估了一组抗体免疫磁分离CMC的效率,目的是进行体外扩增以及基因、免疫和表型特征分析。

方法

在本研究中,五种人葡萄膜黑色素瘤细胞系(92.1、MKT - BR、OCM - 1、SP6.5和UW - 1)用一组针对已知黑色素瘤细胞表面标志物的抗体进行免疫染色。用单克隆抗体PAL M2、NKI C3、NKI/Beteb和9.2.27染色可在这些细胞系中生成细胞表面表达谱。随后将五种人UM细胞系和转染了绿色荧光蛋白(GFP)的92.1以1×10⁶个细胞/毫升至10个细胞/毫升的浓度加入人血液中。细胞在低至10个细胞/毫升的浓度下进行免疫磁分离。

结果

仅当联合使用抗体时,才能在低至10个细胞/毫升人血液的浓度下对所有五种测试的人UM细胞系进行免疫磁分离。单独使用时,这些抗体在生理相关浓度下无法分离细胞。

结论

本研究中提出的免疫磁分离方法可用于在生理相关浓度下分离CMC,其灵敏度与聚合酶链反应(PCR)相当。此外,我们的数据表明,对于UM中CMC的分离,我们的方法比目前使用的方法更有效、更可靠。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f913/2263013/93386001f96c/mv-v14-50-f1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验